NeuroRX

, Volume 3, Issue 2, pp 207–216 | Cite as

Intervention for autistic spectrum disorders

  • Pauline A. Filipek
  • Robin Steinberg-Epstein
  • Teri M. Book
Article

Summary

A comprehensive approach to the assessment of any child with autism must be matched specifically to each individual child and family. This premise holds for medical therapies and special education services as well as psychopharmacologic interventions. Behavioral, as opposed to pharmacologic, treatment is the hallmark of effective intervention for autism. Physicians involved in the care of children with autism need to become familiar with educational law and intervention recommendations. Goals should include improved functional verbal and nonverbal communication and social skills, increased engagement in developmentally appropriate activities, improved fine and gross motor skills, and the development of independent academic and organizations skills, as well as replacement of problem behaviors with developmentally appropriate behaviors. Medicating children with autism is difficult, but is often necessary for chronic behavioral difficulties. In the absence of clear and present guidelines, we have attempted to use evidence and clinical experience to suggest an algorithm based on symptom clusters. Although children with autism may be responsive to medications at lower doses and more susceptible to side effects than other children, medical intervention can produce a significant improvement in the quality of life for the child and family. Careful thought leading to correct identification of target behaviors can appropriately direct better alternatives for medication. Although these approaches are costly and time-consuming endeavors, the expenditure of such efforts is the only available pathway to improve the potential outcomes for individuals with autism as well as decrease the lifetime societal costs for each individual.

Key Words

Autism treatment intervention special education psychopharmacology IDEA 

References

  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Ed 4. Washington, DC: American Psychiatric Association, 1994.Google Scholar
  2. 2.
    Kanner L. Autistic disturbances of affective contact.Nervous Child 2: 217–250, 1943.Google Scholar
  3. 3.
    Waltz M, Shattock P, Carrey NJ. Autistic disorder in nineteenth-century London: three case reports Itard’s 1828 memoire on “Mutism caused by a lesion of the intellectual functions”: a historical analysis.Autism 8: 7–20, 2004.PubMedCrossRefGoogle Scholar
  4. 4.
    Carrey NJ. Itard’s 1828 memoire on “Mutism caused by a lesion of the intellectual functions”: a historical analysis.J Am Acad Child Adolesc Psychiatry 34: 1655–1661, 1995.PubMedCrossRefGoogle Scholar
  5. 5.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1952.Google Scholar
  6. 6.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Ed 2. Washington, DC: American Psychiatric Association, 1968.Google Scholar
  7. 7.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Ed 3. Washington, DC: American Psychiatric Association, 1980.Google Scholar
  8. 8.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Ed 3, Revised. Washington, DC: American Psychiatric Association, 1987.Google Scholar
  9. 9.
    World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva: World Health Organization, 1993.Google Scholar
  10. 10.
    Lotter V. Epidemiology of autistic conditions in young children. I. Prevalence.Soc Psychiatry 1: 124–137, 1966.CrossRefGoogle Scholar
  11. 11.
    Baird G, Charman T, Baron-Cohen S, Cox A, Swettenham J, Wheelwright S et al. A screening for autism at 18 months of age: a 6-year follow-up study.J Am Acad Child Adolesc Psychiatry 39: 694–702, 2000.PubMedCrossRefGoogle Scholar
  12. 12.
    Centers for Disease Control and Prevention. Prevalence of autism in Brick Township, New Jersey, 1998: community report. Atlanta, GA: Center for Disease Control and Prevention, 2000.Google Scholar
  13. 13.
    Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children.JAMA 285: 3093–3099, 2001.PubMedCrossRefGoogle Scholar
  14. 14.
    US Census Bureau. Fact Sheet: 2004 American community survey data profile highlights, 2005 Available at: http://factfinder.census.gov/servlet/ACSSAFFFacts?_event=&geo_id=01000US&_geo Context=01000US&_street=&_county=&_cityTown=&_state= &_zip=&_lang=en&_sse=on&ActiveGeoDiv=&_useEV=&pctxt =fph&pgsl=010. Accessed January 9, 2006.Google Scholar
  15. 15.
    Bryson SE. Epidemiology of autism: overview and issues outstanding. In: Handbook of autism and pervasive developmental disorders (Cohen DJ, Volkmar FR, eds), Ed 2, pp 41–46. New York: Wiley, 1997.Google Scholar
  16. 16.
    Ehlers S, Gillberg C. The epidemiology of Asperger syndrome: a total population study.J Child Psychol Psychiatry 34: 1327–1350, 1993.PubMedCrossRefGoogle Scholar
  17. 17.
    Wing L, Gould J. Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification.J Autism Dev Disord 9: 11–29, 1979.PubMedCrossRefGoogle Scholar
  18. 18.
    McLennan JD, Lord C, Schopler E. Sex differences in higher functioning people with autism.J Autism Dev Disord 23: 217–227, 1993.PubMedCrossRefGoogle Scholar
  19. 19.
    Volkmar FR, Szatmari P, Sparrow SS. Sex differences in pervasive developmental disorders.J Autism Dev Disord 23: 579–591, 1993.PubMedCrossRefGoogle Scholar
  20. 20.
    Allen DA. Autistic spectrum disorders: clinical presentation in preschool children.J Child Neurol 3 (Suppl): S48-S56, 1988.PubMedCrossRefGoogle Scholar
  21. 21.
    Wing L. The continuum of autistic disorders. In: Diagnosis and assessment in autism (Schopler E, Mesibov GM, eds), pp 91–110. New York: Plenum, 1988.Google Scholar
  22. 22.
    Wing L. The autistic spectrum.Lancet 350: 1761–1766, 1997.PubMedCrossRefGoogle Scholar
  23. 23.
    Porter B, Goldstein E, Galil A, Carel C. Diagnosing the ‘strange’ child.Child Care Health Dev 18: 57–63, 1992.PubMedCrossRefGoogle Scholar
  24. 24.
    Deb S, Prasad KB. The prevalence of autistic disorder among children with a learning disability.Br J Psychiatry 165: 395–399, 1994.PubMedCrossRefGoogle Scholar
  25. 25.
    Bhaumik S, Branford D, McGrother C, Thorp C. Autistic traits in adults with learning disabilities.Br J Psychiatry 170: 502–506, 1997.PubMedCrossRefGoogle Scholar
  26. 26.
    Jensen VK, Larrieu JA, Mack KK. Differential diagnosis between Attention-Deficit/ Hyperactivity Disorder and Pervasive Developmental Disorder-Not Otherwise Specified.Clin Pediatr 36: 555–561, 1997.CrossRefGoogle Scholar
  27. 27.
    Filipek PA, Accardo PJ, Baranek GT, Cook EH Jr, Dawson G, Gordon B et al. The screening and diagnosis of autistic spectrum disorders.J Autism Dev Disord 29: 437–482, 1999.CrossRefGoogle Scholar
  28. 28.
    Hirtz D, Wagner A, Filipek PA. The autistic spectrum disorders. In: Pediatric neurology: principles and practice (Swaiman KF, Ashwal S, Ferreiro DM, eds), Ch 37. Philadelphia: WB Saunders-Mosby, 2006.Google Scholar
  29. 29.
    Volkmar FR, Paul R, Klin A, Cohen DJ, eds. Handbook of autism and pervasive developmental disorders, Ed 3. New York: Wiley, 2005.Google Scholar
  30. 30.
    Lord C, Bristol-Power M, Cafiero JM, Filipek PA, Gallagher JJ, Harris SL et al. Educating children with autism. Report of the Committee on Educational Interventions for Autistic Children (Lord C, McGee JP, eds). Washington, DC: National Academy of Science, National Academies Press, 2001.Google Scholar
  31. 31.
    JADD Special Issue: NAS Workshop Papers.J Autism Dev Disord 32:349-508, 2002.Google Scholar
  32. 32.
    Steinbrook R. Testing medications in children.N Engl J Med 347: 1462–1470, 2002.PubMedCrossRefGoogle Scholar
  33. 33.
    Blumer JL. Off-label uses of drugs in children.Pediatrics 104: 598–602, 1999.PubMedGoogle Scholar
  34. 34.
    Filipek PA. Medical aspects of autism. In: Handbook of autism and pervasive developmental disorders (Volkmar FR, Klin A, Paul R, Cohen DJ, eds) Ch 20, pp 534–578. New York: Wiley, 2005.Google Scholar
  35. 35.
    McDougle CJ, Posey DJ. Genetics of childhood disorders: XLIV Autism. Part 3: Psychopharmacology of autism.J Am Acad Child Adolesc Psychiatry 41: 1380–1383, 2002.PubMedCrossRefGoogle Scholar
  36. 36.
    Walkup JT, Labellarte MJ, Riddle MA, Pine DS, Greenhill L, Klein R et al. Fluvoxamine for the treatment of anxiety disorders in children and adolescents.N Engl J Med 344: 1279–1285, 2001.CrossRefGoogle Scholar
  37. 37.
    Lewis MH, Lazoritz M. Psychopharmacology of autism spectrum disorders.Psychiatric Times 22, 2005.Google Scholar
  38. 38.
    Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences.J Child Adolesc Psychopharmacol 15: 116–126, 2005.PubMedCrossRefGoogle Scholar
  39. 39.
    Martin A, Scahill L, Klin A, Volkmar FR. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.J Am Acad Child Adolesc Psychiatry 38: 923–931, 1999.PubMedCrossRefGoogle Scholar
  40. 40.
    Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.Neuropsychopharmacology 30: 582–589, 2005.PubMedCrossRefGoogle Scholar
  41. 41.
    Buitelaar JK, Willemsen-Swinkels SH. Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.Paediatrics Drugs 2: 67–81, 2000.Google Scholar
  42. 42.
    Quintana H, Birmaher B, Stedge D, Lennon S et al. Use of methylphenidate in the treatment of children with autistic disorder.J Autism Dev Disord 25: 283–294, 1995.PubMedCrossRefGoogle Scholar
  43. 43.
    Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.Arch Gen Psychiatry 62:1266-1274, 2005.Google Scholar
  44. 44.
    McDougle CJ, Stigler KA, Posey DJ. Treatment of aggression in children and adolescents with autism and conduct disorder.J Clin Psychiatry 64: 16–25, 2003.PubMedGoogle Scholar
  45. 45.
    Anderson LT, Campbell M, Actams P, Small AM, Perry R, Shell J. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.J Autism Dev Disord 19: 227–239, 1989.PubMedCrossRefGoogle Scholar
  46. 46.
    McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG et al. Risperidone in children with autism and serious behavioral problems.N Engl J Med 347: 314–321, 2002.PubMedCrossRefGoogle Scholar
  47. 47.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.Pediatrics 114: e634-e641, 2004.PubMedCrossRefGoogle Scholar
  48. 48.
    Di Martino A, Tuchman RF. Antiepileptic drugs:affective use in autism spectrum disorders.Pediatric Neurol 25: 199–207, 2001.CrossRefGoogle Scholar
  49. 49.
    Hellings JA, Weckbaugh M, Nickel EJ, Cain SE, Zarcone JR, Reese RM et al. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders.J Child Adolesc Psychopharmacol 15: 682–692. 2005.PubMedCrossRefGoogle Scholar
  50. 50.
    Owley T, Salt J, Guter S, Grieve A, Walton L, Ayuyao N et al. A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.J Child Adolesc Psychopharmacology (in press).Google Scholar
  51. 51.
    Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J. Volumetric MRI analysis comparing attention-deficit hyperactivity disorder and normal controls.Neurology 48: 589–601, 1997.PubMedCrossRefGoogle Scholar

Copyright information

© The American Society for Experimental NeuroTherapeutics, Inc. 2006

Authors and Affiliations

  • Pauline A. Filipek
    • 1
    • 2
    • 4
  • Robin Steinberg-Epstein
    • 1
    • 3
  • Teri M. Book
    • 1
    • 2
  1. 1.Department of PediatricsUniversity of California, Irvine, School of MedicineIrvine
  2. 2.Divisions of Child NeurologyUniversity of California, Irvine, School of MedicineIrvine
  3. 3.Developmental and Behavioral PediatricsUniversity of California, Irvine, School of MedicineIrvine
  4. 4.UC Irvine School of MedicineOrange

Personalised recommendations